Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Niklas von Krosigk"'
Autor:
Debashish Ray, Kaitlin U. Laverty, Arttu Jolma, Kate Nie, Reuben Samson, Sara E. Pour, Cyrus L. Tam, Niklas von Krosigk, Syed Nabeel-Shah, Mihai Albu, Hong Zheng, Gabrielle Perron, Hyunmin Lee, Hamed Najafabadi, Benjamin Blencowe, Jack Greenblatt, Quaid Morris, Timothy R. Hughes
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Thousands of RNA-binding proteins (RBPs) crosslink to cellular mRNA. Among these are numerous unconventional RBPs (ucRBPs)—proteins that associate with RNA but lack known RNA-binding domains (RBDs). The vast majority of ucRBPs have unchara
Externí odkaz:
https://doaj.org/article/1bc102f75ce84e278ddced7e0d6825bd
Autor:
Natalie C. Marshall, Maichael Thejoe, Theo Klein, Antonio Serapio-Palacios, Andrew S. Santos, Niklas von Krosigk, Jayachandran N. Kizhakkedathu, Nikolay Stoynov, Leonard J. Foster, Christopher M. Overall, B. Brett Finlay
Publikováno v:
mSystems, Vol 5, Iss 3 (2020)
ABSTRACT Enteropathogenic Escherichia coli (EPEC) causes severe diarrheal disease and is present globally. EPEC virulence requires a bacterial type III secretion system to inject >20 effector proteins into human intestinal cells. Three effectors trav
Externí odkaz:
https://doaj.org/article/1402921ca80f4af2a5b9f1c2be9331a2
Autor:
Tobias Maetzig, Jens Ruschmann, Lea Sanchez Milde, Courteney K. Lai, Niklas von Krosigk, R. Keith Humphries
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 54-65 (2017)
Tracking the behavior of leukemic samples both in vitro and in vivo plays an increasingly large role in efforts to better understand the leukemogenic processes and the effects of potential new therapies. Such work can be accelerated and made more eff
Externí odkaz:
https://doaj.org/article/6b595f88b78a4bd8ab97383d7c8c50df
Autor:
Lea Sanchez Milde, Jens Ruschmann, R. Keith Humphries, Courteney Lai, Tobias Maetzig, Niklas von Krosigk
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 6, Iss C, Pp 54-65 (2017)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Tracking the behavior of leukemic samples both in vitro and in vivo plays an increasingly large role in efforts to better understand the leukemogenic processes and the effects of potential new therapies. Such work can be accelerated and made more eff
Autor:
Christopher M. Overall, Natalie C. Marshall, Theo Klein, Niklas von Krosigk, Jayachandran N. Kizhakkedathu, B. Brett Finlay, Maichael Thejoe
Publikováno v:
Journal of Proteome Research, 17(12), 4279-4296. American Chemical Society
The human genome encodes ∼20 mitochondrial proteases, yet we know little of how they sculpt the mitochondrial proteome, particularly during important mitochondrial events such as the initiation of apoptosis. To characterize global mitochondrial pro
Autor:
Christopher May, Patricia Rosten, Anton Selich, Tobias Maetzig, Jens Ruschmann, Niklas von Krosigk, Michael Rothe, Axel Schambach, R. Keith Humphries, Mor Ngom, Gudmundur L. Norddahl, Lea Sanchez Milde, Suzan Imren, Courteney Lai, Ishpreet Dhillon
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 25(3)
Retroviral integration site analysis and barcoding have been instrumental for multiplex clonal fate mapping, although their use imposes an inherent delay between sample acquisition and data analysis. Monitoring of multiple cell populations in real ti
Autor:
Patricia Rosten, Niklas von Krosigk, Tobias Maetzig, Courteney Lai, Lea Sanchez-Milde, R. Keith Humphries, Tanner Lohr, Gudmundur L. Norddahl
Publikováno v:
Experimental Hematology. 44:S85-S86